Cancer Breakthroughs: New Drugs, Therapies Transforming Treatment Options

A brave idea is making cancer treatment a little less frightening for children

Korean biopharmaceutical group HLB is getting a second shot at U.S. Food and Drug Administration (FDA) approval for its flagship liver cancer therapy. The FDA has officially accepted a resubmitted …

For cancer patients who travel to Kampala for treatment, and the relatives who stay beside...

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, and collaborators have pioneered a new approach to preventing dangerous …

Researchers have developed a promising new approach that uses synthetic DNA molecules to target cancer-linked genes directly, opening new possibilities for future treatments, diagnostics and …

Brazilian scientist Matheus dos Santos Farias, 26, has developed a mathematical equation that could contribute to research into potential treatments for prostate cancer. In an interview with Só …

Scientists are exploring a potentially overlooked factor behind some of the most treatment-resistant cancers: bacteria lurking inside tumors.

Researchers have developed a promising new approach that uses synthetic DNA molecules to target cancer-linked genes directly, opening new possibilities for future treatments, diagnostics and …

AI-supported screening strategy could improve cervical cancer detection in low-resource settings | !

When visualized as a traditional map, the new breast cancer atlas resembles an archipelago, where distinct breast cancer subtypes that share common molecular features, treatment responses and …

Image Courtesy: Shutterstock Scientists at the University of California, San Francisco (UCSF) have developed an experimental immune cell therapy that

Her son needs cancer treatments, but there's a big problem brewing at his hospital

Researchers have developed a promising new approach that uses synthetic DNA molecules to target cancer-linked genes directly, opening new possibilities for future treatments, diagnostics and …

A new approach to engineering immune cells has shown remarkable success against a deadly childhood brain cancer in mice.

A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls …

The treatment is already approved for some indications in China and could mark a shift in how cancers are treated, researchers say.

Scientists at the University of North Carolina Lineberger Comprehensive Cancer Center have discovered an unexpected role for a key innate immune protein, revealing how it helps regulate cholesterol …

Patients with head and neck cancer who attended a survivorship clinic before completing RT were more likely to complete treatment on schedule and had better 3-year DFS than those who did not attend.

Some cases of the most common childhood cancer, B-cell acute lymphoblastic leukemia (B-ALL), return after treatment - and genetic changes present from the start may help explain why.

Laboratoires Pierre Fabre announces the approval of BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer …

A natural plant compound may help overcome a built-in defense that allows many cancers to resist a class of drugs designed to restore normal gene activity, according to a study by researchers at the …

Douglas Mitchell, PhD, with the Vanderbilt-Ingram Cancer Center, who is director of the Vanderbilt Institute of Chemical Biology, the William Kelly Warren Sr. Chair in Biochemistry, and professor of …

Co-corresponding author, Scott Blanchard, PhD, (left), and co-first author Aaron Cruz-Navarrette, PhD, (right), discuss their recent findings that identify how one factor in mRNA decoding can be …

Jennifer Schaefer Child Support Room to provide children space while parents undergo treatment

Post-Enhertu HER2 breast cancer treatment candidate IKS014 (caxmotabart entudotin) posted a 50% response rate in 10 evaluable patients previously treated with Enhertu - a setting where Kadcyla …

One man is waiting for cancer treatment, another has spent two years with a catheter waiting for an operation. This is the reality of the health system under National', says Labour health …

Learn how St. Jude scientists, led by Scott Blanchard, PhD, identified the translation regulation mechanisms involved in mRNA deocding are involved in cancer development and treatment resistance....

One young woman shares what it was like to balance breast cancer treatment with her professional ambitions.

Prof. Cai Jing said that using THI to identify patients most likely to benefit from specific treatments could not only improve overall treatment outcomes but also spare patients unnecessary side …

Learn how St. Jude scientists, led by Scott Blanchard, PhD, identified the translation regulation mechanisms involved in mRNA decoding are involved in cancer development and treatment resistance.

UCLA researchers found that boosting p53 protein with navtemadlin helped T cells fight melanoma cancer cells longer, but dosing challenges remain.

Researchers at Roswell Park Comprehensive Cancer Center have identified a promising strategy for overcoming one of the biggest challenges facing KRAS-targeted cancer therapies: treatment resistance. …